Print Issue: October 2020

Mood Disorder Information Center

Pharmacogenetic Testing: Does it Improve Therapy in Patients With MDD?

By

Lauren Nolan, MMSc, PA-C

Tia M. Solh, MT (ASCP), MSPAS, PA-C

September 10, 2020

Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.

Next post in Mood Disorder Information Center

No Support for Vitamin D3 Supplementation to Prevent Depression Among Older Adults